BETA 2-MICROGLOBULIN - ANVISA Registration 10339840229

Access comprehensive regulatory information for BETA 2-MICROGLOBULIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10339840229 and manufactured by DIASORIN ITALIA S.P.A.. The registration is held by DIASORIN LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LIMITED, THE BINDING SITE GROUP LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10339840229
Registration Details
ANVISA Registration Number: 10339840229
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

LIAISON ß2- MICROGLOBULINA
Risk Class II

Registration Details

10339840229

25351054504200694

01896764000170

Company Information

Italy
PT: ITÁLIA

Dates and Status

Apr 24, 2006

VIGENTE

09/18/2025 19:00:01